Evaluation of Safety and Efficacy of Glaritus&lt;sup&gt;&amp;reg;&lt;/sup&gt; versus Lantus&lt;sup&gt;&amp;reg;&lt;/sup&gt; in Combination with Insulin Lispro among Adults with Type 1 Diabetes Mellitus-Phase IV Study

Insulin Lispro ◽

Safety And Efficacy ◽

Phase Iv

A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus

Case Medical Research ◽

10.31525/ct1-nct03981627 ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Aspart ◽

Safety And Efficacy

Access to Source Data/Documents (Part 10 of Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-onset Type 1 Diabetes Mellitus) v1 (protocols.io.bvegn3bw)

protocols.io ◽

10.17504/protocols.io.bvegn3bw ◽

2021 ◽

Author(s):

Stephen.Gitelman not provided ◽

Jeffrey A.

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Beta Cell ◽

Beta Cell Function ◽

Cell Function ◽

Safety And Efficacy ◽

Source Data ◽

Schedule of Events (Appendix 1 of "Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-onset Type 1 Diabetes Mellitus") v1 (protocols.io.bvf6n3re)

protocols.io ◽

10.17504/protocols.io.bvf6n3re ◽

2021 ◽

Author(s):

Stephen.Gitelman not provided ◽

Jeffrey A.

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Beta Cell ◽

Beta Cell Function ◽

Cell Function ◽

Safety And Efficacy ◽

Onset Type ◽

Mechanistic Assays (Part 7 of Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-onset Type 1 Diabetes Mellitus) v1 (protocols.io.bvdcn22w)

protocols.io ◽

10.17504/protocols.io.bvdcn22w ◽

2021 ◽

Author(s):

Stephen.Gitelman not provided ◽

Jeffrey A.

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Beta Cell ◽

Beta Cell Function ◽

Cell Function ◽

Safety And Efficacy ◽

Onset Type ◽

729-P: Efficacy and Safety of Mylan Insulin Glargine Products (MYL-1501D) from Two Manufacturing Processes (Process V and Process VI) in Combination with Insulin Lispro in Subjects with Type 1 Diabetes Mellitus

Diabetes ◽

10.2337/db21-729-p ◽

2021 ◽

Vol 70 (Supplement 1) ◽

pp. 729-P

Author(s):

YARON RAITER ◽

THOMAS BLEVINS ◽

BIN SUN ◽

ANOOP CHULLIKANA ◽

GOPINATH RANGANNA ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Insulin Lispro ◽

Manufacturing Processes ◽

Efficacy And Safety

Eligibility (Part 4 of Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-onset Type 1 Diabetes Mellitus) v1 (protocols.io.bvc4n2yw)

protocols.io ◽

10.17504/protocols.io.bvc4n2yw ◽

2021 ◽

Author(s):

Stephen.Gitelman not provided ◽

Jeffrey A.

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Beta Cell ◽

Beta Cell Function ◽

Cell Function ◽

Safety And Efficacy ◽

Onset Type ◽

Phase IV Study Comparing Diurnal Glycemic Profile Following the Administration of 2 NPH Plus Regular Human DNA Recombinant Insulin Regimens in Type 1 Diabetes Mellitus (T1DM) Adult Patients

Arzneimittelforschung ◽

10.1055/s-0032-1306274 ◽

2012 ◽

Vol 62 (06) ◽

pp. 267-273

Author(s):

E. Feleder ◽

G. Yerino ◽

E. Halabe ◽

J. Tombazzi ◽

J. Farias

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Adult Patients ◽

Human Dna ◽

Recombinant Insulin ◽

Glycemic Profile ◽

Phase Iv

In patients with type??1 diabetes mellitus receiving insulin or insulin lispro, pramlintide* reduces postprandial glucose excursions

Inpharma Weekly ◽

10.2165/00128413-200314120-00015 ◽

2003 ◽

Vol &NA; (1412) ◽

pp. 8

Author(s):

&NA;

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Lispro ◽

Postprandial Glucose

Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog)

Diabetic Medicine ◽

10.1046/j.1464-5491.2003.00840.x ◽

2003 ◽

Vol 20 (1) ◽

pp. 46-50 ◽

Cited By ~ 52

Author(s):

E. A. Masson ◽

J. E. Patmore ◽

P. D. Brash ◽

M. Baxter ◽

G. Caldwell ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Pregnancy Outcome ◽

Insulin Lispro

Objectives (Part 2 of Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-onset Type 1 Diabetes Mellitus) v1 (protocols.io.bvcvn2w6)

protocols.io ◽

10.17504/protocols.io.bvcvn2w6 ◽

2021 ◽

Author(s):

Stephen.Gitelman not provided ◽

Jeffrey A.

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Beta Cell ◽

Beta Cell Function ◽

Cell Function ◽

Safety And Efficacy ◽

Onset Type ◽